Condition: Healthy · Sponsor: Massachusetts General Hospital
This research study aims assess whether the Difference Frequency Generation (DFG) laser could be a better alternative to the CO2 laser in terms of reduced side effects and patient downtime.
This description comes directly from the study's public registry record.
Alicia Van Cott, NP · 617-726-4454 · mansteinlab@mgh.harvard.edu
Amelia Carlson, BS · 617-726-4454 · mansteinlab@mgh.harvard.edu
Always discuss trial participation with your own doctor first.
| MGH Clinical Unit for Research Trials & Outcomes in Skin | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06295471